Filter by
Publications (1999)
RSSFactsheet - Cross-border Healthcare in 2022
SCCS Opinion on on the safety of Silver (CAS/EC No. 7440-22-4/231-131-3) used in cosmetic products
Summary of the 2023 (2022 data) annual reporting of serious adverse reactions and events for blood and blood components
Summary of the 2023 (2022 data) annual reporting of serious adverse reactions and events for tissues and cells
SCHEER - UPDATE of the GUIDELINES on the benefit-risk assessment of the presence of phthalates in certain medical devices covering phthalates which are carcinogenic, mutagenic, toxic to reproduction (CMR) or have endocrine-disrupting (ED) properties
Scientific specifications of medicinal products subject to joint clinical assessments
Guidance on outcomes for joint clinical assessments
Guidance on reporting requirements for multiplicity issues and subgroup, sensitivity and post hoc analyses in joint clinical assessments
Commission Decision (EU) 2024/1514
COM(2024) 214 final - Report from the Commission to the European Parliament and Council on delegated acts concerning biocidal products